Profile Picture
Rewards
  • Search
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
    • Real Estate
    • My Bing
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Calls Swift 'Kelce's wife'
Attends Milei's inauguration
Horse killed, 4 hurt in crash
Dropped by 18 brands
‘I am insecure’
Priest stabbed to death
US F-16 jet crashes in SK
Receives $5B+ buyout offer?
Netanyahu speaks to Putin
Tanks enter Khan Younis
Kids accept Nobel Prize
Has non-Hodgkin's lymphoma
Stabbing at DC jail injures 3
Suffers right hand fracture
Needs $46B for aid in '24
Stephanie Pope as new COO
To invest $1.5B in GoTo
$43M+ overseas debut
Rangers beat Kings 4-1
Defamation suit goes to trial
1-year, $4 million deal
AU to cut migrant intake
Named Browns starting QB
UK sends 2 minehunters
Bills beat Chiefs 20-17
To start military service
Cardi B confirms split
James makes USC debut
Capitals defeat Blackhawks
Former Ky. governor dies
Top search trends for 2023
California hiker rescued
Teases ‘White Lotus’ S3
Cigna shares jump
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
47,100 results
7h
This Week in Chancery Court: AstraZeneca Faces Bullying Claims
The British pharmaceutical giant AstraZeneca Plc will argue before Delaware’s Court of Chancery this week that claims it ...
Bournemouth Daily Echo2mon
AstraZeneca settles heartburn drug legal claims for £352m
Drugs giant AstraZeneca has agreed to settle a raft of legal claims over its heartburn treatments for 425 million US dollars (£352 million). The FTSE 100 listed firm said the agreements will ...
Proactive Investors1mon
AstraZeneca faces lawsuits in High Court over ‘defective’ Covid-19 vaccine
Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is ...
3hon MSN
AstraZeneca's Investigational Drug Shows Durable Clinical Benefit In Patients With Rare Blood Disease
AstraZeneca Plc (NASDAQ: AZN) released results from the 24-week and long-term extension (LTE) period of the ALPHA Phase 3 ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Get the Bing App
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices